Literature DB >> 834224

Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.

R J Deckelbaum, R S Lees, D M Small, S E Hedberg, S M Grundy.   

Abstract

Two patients with nomozygous familial hypercholesterolemia, refractory to medical therapy, underwent complete bile diversion by common-duct ligation and cholecystostomy, in an attempt to arrest the progression of their xanthomatosis and atherosclerosis by depletion of body cholesterol. Clofibrate was given after operation to one patient, and cholic acid to both, in an effort to enhance further the negative sterol balance. Bile diversion produced an increase of six to eight times in gastrointestinal sterol output, which was not increased further by either clofibrate or cholic acid therapy. Despite a calculated sterol loss of 560 g over 14 months in one patient and 400 g over 10 months in the other, neither plasma cholesterol nor xanthoma size decreased. Continuity of the biliary tree was therefore restored. The data suggest that patients with homozygous familial hypercholesterolemia respond to even massive gastrointestinal sterol depletion with equal increases in sterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 834224     DOI: 10.1056/NEJM197703032960901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  7 in total

Review 1.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 2.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Biliary sterol secretion is not required for macrophage reverse cholesterol transport.

Authors:  Ryan E Temel; Janet K Sawyer; Liqing Yu; Caleb Lord; Chiara Degirolamo; Allison McDaniel; Stephanie Marshall; Nanping Wang; Ramesh Shah; Lawrence L Rudel; J Mark Brown
Journal:  Cell Metab       Date:  2010-07-07       Impact factor: 27.287

4.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

5.  Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.

Authors:  Sadik H Kassim; Hui Li; Luk H Vandenberghe; Christian Hinderer; Peter Bell; Dawn Marchadier; Aisha Wilson; Debra Cromley; Valeska Redon; Hongwei Yu; James M Wilson; Daniel J Rader
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

6.  The mechanisms of and the interrelationship between bile acid and chylomicron-mediated regulation of hepatic cholesterol synthesis in the liver of the rat.

Authors:  F O Nervi; J M Dietschy
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

7.  Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.

Authors:  B Angelin; C A Raviola; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.